Ozaraga, Mariane .
HRN: 23-59-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2024
CEFUROXIME 750MG (VIAL)
12/08/2024
12/15/2024
INTRAVENOUS
180 Mg
Every 8 Houra
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes